ArticleFrontiers in oncology2025
Leveraging a foundation model zoo for cell similarity search in oncological microscopy across devices.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cellular imaging analysis using the traditional retrospective approach is extremely time-consuming and labor-intensive. Although AI-based solutions are available, these approaches rely heavily on supervised learning techniques that require high quality, large labeled datasets from the same microscope to be reliable. In addition, primary patient samples are often heterogeneous cell populations and need to be stained to distinguish the cellular subsets. The resulting imaging data is analyzed and labeled manually by experts. Therefore, a method to distinguish cell populations across imaging devices without the need for staining and extensive manual labeling would help immensely to gain real-time insights into cell population dynamics. This especially holds true for recognizing specific cell types and states in response to treatments. Objective: We aim to develop an unsupervised approach using general vision foundation models trained on diverse and extensive imaging datasets to extract rich visual features for cell-analysis across devices, including both stained and unstained live cells. Our method, Entropy-guided Weighted Combinational FAISS (EWC-FAISS), uses these models purely in an inference-only mode without task-specific retraining on the cellular data. Combining the generated embeddings in an efficient and adaptive k-nearest neighbor search allows for automated, cross device identification of cell types and states, providing a strong basis for AI-assisted cancer therapy. Methods: We utilized two publicly available datasets. The WBC dataset includes 14,424 images of stained white blood cell samples from patients with acute myeloid and lymphoid leukemia, as well as those without leukemic pathology. The LISC dataset comprises 257 images of white blood cell samples from healthy individuals. We generated four in-house datasets utilizing the JIMT-1 breast cancer cell line, as well as Jurkat and K562 (leukemic cell lines). These datasets were acquired using the Nanolive 3D Cell Explorer-fluo (CX-A) holotomographic microscope and the BioTek Lionheart FX automated brightfield microscope. The images from the in-house datasets were manually annotated using Roboflow software. To generate the embeddings, we used and optimized a concatenated combination of SAM, DINO, ConvNeXT, SWIN, CLIP and ViTMAE. The combined embeddings were used as input for the adaptive k-nearest neighbor search, building an approximate Hierarchical Navigable Small World FAISS index. We compared EWC-FAISS to fully fined-tuned ViT-Classifiers with DINO-, and SWIN-backbones, a ConvNeXT architecture, as well as to NMTune as a lightweight domain-adaptation method with frozen backbone. Results: EWC-FAISS performed competitively with the baselines on the original datasets in terms of macro accuracy. Macro accuracy is the average of class-specific accuracies, treating all classes equally by averaging their individual accuracies. EWC-FAISS ranked second for the WBC dataset (macro accuracy: 97.6 ± 0.2), first for cell state classification from Nanolive (macro accuracy: 90 ± 0), and performed comparably for cell type classification from Lionheart (macro accuracy: 87 ± 0). For the transfer to out-of-distribution (OOD) datasets, which the model had not seen during training, EWC-FAISS consistently outperformed the other baselines. For the LISC dataset, EWC-FAISS achieved a macro accuracy of 78.5 ± 0.3, compared to DINO FT's 17 ± 1, SWIN FT's 44 ± 14, ConvNeXT FT's 45 ± 9, and NMTune's 52 ± 10. For the cell state classification from Lionheart, EWC-FAISS had a macro accuracy of 86 ± 1, while DINO FT, SWIN FT, and ConvNeXT FT achieved 65 ± 11, 68 ± 16, and 81 ± 1, respectively, and NMTune 81 ± 7. For the transfer of cell type classification from Nanolive, EWC-FAISS attained a macro accuracy of 85 ± 0, compared to DINO FT's 24.5 ± 0.9, SWIN FT's 57 ± 6, ConvNeXT FT's 54 ± 4, and NMTune's 63 ± 4. Additionally, building EWC-FAISS after embedding generation was significantly faster than training DINO FT (∼ 6 minutes compared to Conclusion: We present a novel approach to identify various cell lines and primary cells based on their identity and state using images acquired across various imaging platforms which vary in resolution, magnification and image quality. Despite these differences, we could show that our efficient, adaptive k-nearest neighbor search pipeline can be applied on a large image dataset containing different cell types and effectively differentiate between the cells and their states such as live, apoptotic or necrotic. There are several applications, particularly in distinguishing various cell populations in patient samples or monitoring therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.